content top

Randomized, Double Blind, Controlled Study with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone(IVTA) vs Triple Theraphy with Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone and Intravitreal Ranibizumab in Patients with Subfoveal Choroidal Neovascularization (CNV) Secondary

http://www.evrs.eu/medias/2009/congress/Combined-Treatments.flv Authors: Rosa Maria Romero-Castro, Alfredo Morales, H. Quiroz-Mercado, Mexico Advantages: New modality treatmens are needed to increase effectiveness and reduce number of retreatmens in AMD patients. Triple therapy with PDT, intravitreal triamcinolone and intravitreal ranibizumab can be with less number of treatments and they’re for less cost a safe treatment option for...

Read More

Intravitreal Bevacizumab in Retinopathy of Prematurity: 30 Months Follow-Up. Will we Change our Way of Treating ROP?

http://www.evrs.eu/medias/2008/congress/Intravitreal-Bevacizumab-in-Retinopathy-of-Prematurity:-30-Months-Follow-Up.-Will-we-Change-our-Way-of-Treating-ROP.flv Maria Ana Martinez-Castellanos, Jose Luis Guerrero-Naranjo, J. Gerardo Garcia-Aguirre, Virgilio Morales-Canton, Omar Honerlage-Merino, R.V. Paul Chan, Hugo Quiroz-Mercado Advantages: We present a treatment with antiangiogenic therapy for retinopathy of prematurity with good outcome...

Read More

Pattern Scan Laser System (PaScaL®) vs Conventional Photocoagulation System. Evolving our way to do photocoagulation

http://www.evrs.eu/medias/2008/congress/Pattern-Scan-Laser-System-(PaScaL)-vs-Conventional-Photocoagulation-%20System.-Evolving-our-way-to-do-photocoagulation.flv Maria Ana Martinez-Castellanos, Virgilio Morales-Canton, Lourdes Lopez-Ramos, Sandra Vera-Rodriguez, Raul Velez-Montoya, Octavio Burgos-Vejar, Oscar Alvarez-Verduzco, Adai Perez-Montesinos, Jans Fromow-Guerra, Jessica Lopez-Miranda, Hugo Quiroz-Mercado Advantages: Pattern scan...

Read More

Safety and Efficacy of Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Pathologic Myopia

Myriam Lucia Hernandez-Rojas, MD (Mexico City, Jose Dalma- Weiszhausz, MD (MexicoCity, Mexico), Hugo Quiroz- Mercado, MD (Mexico City, Mexico), Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), Griselda Alvarez-Rivera, MD (Mexico City, Mexico), Maura Abraham-Marin, MD (Mexico City, Mexico), Adriana Solis-Vivanco, MD (Mexico City, Mexico), Elizabeth Reyna-Castelan, MD (Mexico City, Mexico), Jose Luis Guerrero-Naranjo,MD (Mexico City,...

Read More

Efficacy of Intravitreal Bevacizumab for Severe Nonproliferative, Proliferative Diabetic Retinopathy and Active Photocoagulated Retinopathy

Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), Elizabeth Reyna-Castelán, MD (Mexico City, Mexico), Juan Manuel Jimenez- Sierra, MD (Mexico City, Mexico), Adriana Solis-Vivanco, MD (Mexico City, Mexico), Jose Luis Guerrero-Naranjo, MD (Mexico City, Mexico), Maura Abraham-Marin, MD (Mexico City, Mexico), Myriam Lucia Hernández-Rojas, MD (Mexico City, Mexico), Griselda Alvarez-Rivera, MD (Mexico City, Mexico), Maria Ana Martinez-...

Read More

Intravitreal Bevacizumab Therapy for Neovascular Age-related Macular Degeneration: A Pilot Study

Virgilio Morales-Canton, MD (Mexico City, Mexico), Maura Lucy Abraham Marin, MD (Mexico City, Mexico), Carlos Fernando Cortes Luna, MD (Bogota, Colombia), Lidia Griselda Alvarez-Rivera, MD (Mexico City, Mexico), Myriam L Hernandez-Rojas, (Mexico City, Mexico), Hugo Quiroz-Mercado, MD (Mexico City, Mexico) PURPOSE: Evaluate efficacy and safety of intravitreal bevacizumab therapy for neovascular age-related macular degeneration...

Read More

Primary Intravitreal Bevacizumab (Avastin) for the Treatment of CNV Secondary to AMD: Results of the Pan-American Collaborative Retina Study Group

http://www.evrs.eu/medias/2006/congress/Primary-Intravitreal-Bevacizumab-(Avastin)-for-the-Treatment-of-CNV-Secondary-to-AMD:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.swf Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), Juan G. Sanchez, MD (Caracas, Venezuela), Lihteh Wu, MD (San Jose, Costa Rica), Jose Dalma-Weiszhausz,...

Read More

Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic Macular Edema: Results of the Pan-American Collaborative Retina Study Group

http://www.evrs.eu/medias/2006/congress/Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Diabetic-Macular-Edema:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.swf http://www.evrs.eu/medias/2006/congress/Primary%20Intravitreal%20Bevacizumab%20(Avastin)%20for%20the%20Treatment%20of%20Diabetic-Macular-Edema:-Results-of-the-Pan-American-Collaborative-Retina-Study-Group.flv J. Fernando Arevalo, MD, FACS (Caracas,...

Read More

Multifocal Electrophysiologic Findings after Intravitreal Bevacizumab (Avastin) Treatment

Myriam Lucia Hernandez-Rojas, MD (Mexico City, Mexico), Juan Manuel Jimenez-Sierra, MD (Mexico City, Mexico), Hugo Quiroz- Mercado, MD (Mexico City, Mexico), Mitzy Elena Torres-Soriano, MD (Mexico City, Mexico), Jose Luis Diaz-Rubio, MD (Mexico City, Mexico), Victoria Cubas, MD (Mexico City, Mexico), Maria Ana Martinez-Castellanos, MD (Mexico City, Mexico), Jose Luis Guerrero- Naranjo, MD (Mexico City, Mexico), Jans Fromow-Guerra, MD, PhD...

Read More

Safety of an Intravitreal Injection of Bevacizumab (Avastin®): Results of a Multicenter Trial

Lihteh Wu, MD (San Jose, Costa Rica), Maria A. Martinez- Castellanos, MD (Mexico City, Mexico), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Michel Eid Farah, MD, PhD (São Paulo, Brazil), Maria H. Berrocal, MD (Santurce, PR), Jose A. Roca, MD (Lima, Peru), Francisco J. Rodriguez, MD (Bogota, Colombia), Mauricio Maia, MD (São Paulo, Brazil), Teodoro Evans, MD (San Jose, Costa Rica), Pan...

Read More

Intravitreal Bevacizumab (Avastin) as Treatment for Macular Edema in Vein Occlusions

Jose Luis Guerrero-Naranjo, MD (Mexico City, Mexico), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), Virgilio Morales- Canton, MD (Mexico City, Mexico), Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), Griselda Alvarez-Rivera, MD (Mexico City,Mexico), Adriana Solis-Vivanco, MD (Mexico City, Mexico), Elizabeth Reyna-Castelan, MD (Mexico City, Mexico), Maura Abraham, MD (Mexico City, Mexico), Juan Manuel Jimenez-Sierra, MD (Mexico City,...

Read More

Safety and Efficacy of Intravitreal Bevacizumab for Retinopathy of Prematurity

http://www.evrs.eu/medias/2006/congress/Safety-and-Efficacy-of-Intravitreal-Bevacizumab-for-Retinopathy-of-Prematurity.swf http://www.evrs.eu/medias/2006/congress/Safety-and-Efficacy-of-Intravitreal-Bevacizumab-for-Retinopathy-of-Prematurity.flv Hugo Quiroz-Mercado, MD (Mexico City, Mexico), ACV Travassos, MD (Lisboa, Portugal), Maria Ana Martinez-Castellanos, MD (Mexico City, Mexico, Mexico), Griselda Alvarez-Rivera, MD (Mexico City,...

Read More

Artificial Bruch’s Membrane Implant: Preliminary Result on Animal

http://www.evrs.eu/medias/2005/congress/Artificial-Bruch-s-Membrane-Implant:-Preliminary-Result-on-Animal.swf F. Patelli, MD, H. Quiroz-Mercado, MD, M. S. Blumenkranz, MD, R. Agurto-Rivera, MD, D. Yellachich, MD, F. Molnar, MD, T. Leng, MD, R. Dalal, MD, G. Alvarez-Rivera, MD Purpose: To describe surgical procedure of subretinal artificial Bruch’s membrane implant and to evaluate its biocompatibility in pigs eyes. Methods: 12 pigs eyes...

Read More
content top